Literature DB >> 27696209

Impact of Delta Hemoglobin on Provider Transfusion Practices and Post-operative Morbidity Among Patients Undergoing Liver and Pancreatic Surgery.

Gaya Spolverato1, Fabio Bagante1, Matthew Weiss1, Jin He1, Christopher L Wolfgang1, Fabian Johnston1, Martin A Makary1, Will Yang1, Steven M Frank2, Timothy M Pawlik3,4.   

Abstract

BACKGROUND: Delta hemoglobin (ΔHb) is defined as the difference between the preoperative Hb and the lowest post-operative Hb level. We sought to define the impact of ΔHb relative to nadir Hb levels on the likelihood of transfusion, as well as characterize the impact of ΔHb and nadir Hb on morbidity among a large cohort of patients undergoing complex hepatopancreatobiliary (HPB) surgery.
METHODS: Patients who underwent pancreatic or hepatic resection between January 1, 2009 and June 30, 2015 at Johns Hopkins Hospital were identified. Data on the perioperative ΔHb, nadir Hb, as well as blood utilization were obtained and analyzed. Multivariable logistic regression models were used to identify the factors associated with ΔHb and the impact of ΔHb on perioperative morbidity. A Bayesian model was used to evaluate the correlation of ΔHb and nadir Hb with the likelihood of transfusion, as well as the impact on morbidity.
RESULTS: A total of 4363 patients who underwent hepatobiliary (n = 2200, 50.4 %) or pancreatic (n = 2163, 49.6 %) surgery were identified. More than one quarter of patients received at least one unit of packed red blood cells (PRBC) (n = 1187, 27.2 %). The median nadir Hb was 9.2 (IQR 7.9-10.5) g/dL resulting in an average ΔHb of 3.4 mg/dL (IQR 2.2-4.7) corresponding to 26.3 %. Both ΔHb and nadir Hb strongly influenced provider behavior with regards to use of transfusion. Among patients with the same nadir Hb, ΔHb was strongly associated with use of transfusion; among patients who had a nadir Hb ≤6 g/dL, the use of transfusion was only 17.9 % when the ΔHb = 10 % versus 49.1 and 80.9 % when the ΔHb was 30 or 50 %, respectively. Perioperative complications occurred in 584 patients (13.4 %) and were more common among patients with a higher value of ΔHb, as well as patients who received PRBC (both P < 0.001).
CONCLUSIONS: The combination of the Hb trigger with ΔHb was associated with transfusion practices among providers. Larger ΔHb values, as well as receipt of transfusion, were strongly associated with risk of perioperative complication following HPB surgery.

Entities:  

Keywords:  Delta; Hemoglobin; Hepatopancreatobiliary; Outcomes; Surgery

Mesh:

Substances:

Year:  2016        PMID: 27696209     DOI: 10.1007/s11605-016-3279-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  33 in total

1.  A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study.

Authors:  Peter C Austin; Paul Grootendorst; Geoffrey M Anderson
Journal:  Stat Med       Date:  2007-02-20       Impact factor: 2.373

Review 2.  2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines.

Authors:  Victor A Ferraris; Jeremiah R Brown; George J Despotis; John W Hammon; T Brett Reece; Sibu P Saha; Howard K Song; Ellen R Clough; Linda J Shore-Lesserson; Lawrence T Goodnough; C David Mazer; Aryeh Shander; Mark Stafford-Smith; Jonathan Waters; Robert A Baker; Timothy A Dickinson; Daniel J FitzGerald; Donald S Likosky; Kenneth G Shann
Journal:  Ann Thorac Surg       Date:  2011-03       Impact factor: 4.330

3.  Association between hospital intraoperative blood transfusion practices for surgical blood loss and hospital surgical mortality rates.

Authors:  Wen-Chih Wu; Amal Trivedi; Peter D Friedmann; William G Henderson; Tracy S Smith; Roy M Poses; Georgette Uttley; Michael Vezeridis; Charles B Eaton; Vincent Mor
Journal:  Ann Surg       Date:  2012-04       Impact factor: 12.969

Review 4.  Perioperative Blood Transfusion and the Prognosis of Pancreatic Cancer Surgery: Systematic Review and Meta-analysis.

Authors:  Michael N Mavros; Li Xu; Hadia Maqsood; Faiz Gani; Aslam Ejaz; Gaya Spolverato; Waddah B Al-Refaie; Steven M Frank; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2015-08-21       Impact factor: 5.344

5.  Age of Transfused Blood Impacts Perioperative Outcomes Among Patients Who Undergo Major Gastrointestinal Surgery.

Authors:  Yuhree Kim; Neda Amini; Faiz Gani; Doris Wagner; Daniel J Johnson; Andrew Scott; Aslam Ejaz; Georgios A Margonis; Li Xu; Stefan Buettner; Jack O Wasey; Ruchika Goel; Steven M Frank; Timothy M Pawlik
Journal:  Ann Surg       Date:  2017-01       Impact factor: 12.969

6.  Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery.

Authors:  Laurent G Glance; Andrew W Dick; Dana B Mukamel; Fergal J Fleming; Raymond A Zollo; Richard Wissler; Rabih Salloum; U Wayne Meredith; Turner M Osler
Journal:  Anesthesiology       Date:  2011-02       Impact factor: 7.892

7.  Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery.

Authors:  Manoj Kuduvalli; Aung Y Oo; Nick Newall; Antony D Grayson; Mark Jackson; Michael J Desmond; Brian M Fabri; Abbas Rashid
Journal:  Eur J Cardiothorac Surg       Date:  2005-04       Impact factor: 4.191

8.  Variation in triggers and use of perioperative blood transfusion in major gastrointestinal surgery.

Authors:  A Ejaz; G Spolverato; Y Kim; S M Frank; T M Pawlik
Journal:  Br J Surg       Date:  2014-08-05       Impact factor: 6.939

9.  Effect of Relative Decrease in Blood Hemoglobin Concentrations on Postoperative Morbidity in Patients Who Undergo Major Gastrointestinal Surgery.

Authors:  Gaya Spolverato; Yuhree Kim; Aslam Ejaz; Steven M Frank; Timothy M Pawlik
Journal:  JAMA Surg       Date:  2015-10       Impact factor: 14.766

10.  Phosphoglycolate phosphatase and 2,3-diphosphoglycerate in red cells of normal and anemic subjects.

Authors:  R Somoza; E Beutler
Journal:  Blood       Date:  1983-10       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.